UnitedHealth Group reported better-than-expected Q3 2026 results, beating both revenue and earnings estimates. The company raised its full-year guidance, reflecting a turnaround driven by shedding unprofitable units and investing in efficiency and technology. Margins improved notably, with Medical Care Ratio (MCR) and Operating Cost Ratio (OCR) outperforming expectations. Shareholders benefit from a combined yield near 5%, including dividends and buybacks, supported by strong cash flow. The outlook remains positive with a 'Buy' rating and a price target of $440 per share, indicating potential upside as the market has yet to fully price in these improvements.
UnitedHealth Group shares are trading at USD 380.74 on Pluang as of Oct 13, 2026 23:31 WIB, showing a modest 0.59% gain in the last day. The stock remains well below its 52-week high of USD 436.35, suggesting room for growth despite recent positive earnings and guidance upgrades. Pluang investors hold the stock for an average of 98 days, with a majority (64%) currently buying, reflecting confidence in the company’s turnaround story.
UnitedHealth Group reported strong Q3 2026 results, with adjusted earnings per share of $4.69, surpassing estimates of $4.14. Revenue also exceeded expectations at $112.70 billion. The company raised its full-year outlook, reflecting solid operationa...
UnitedHealth Group raised its 2026 earnings outlook following a 52% increase in third-quarter operating profit to $6.6 billion, driven by lower medical costs and better operational efficiency. The company now expects adjusted earnings of at least $20...
UnitedHealth shares rose 4% after beating Q3 2026 earnings estimates with adjusted EPS of $4.69 and raising its full-year outlook to at least $20.50. The earnings beat was driven by improved medical care ratio, helped partly by a $610 million reserve...
UnitedHealth Group reported Q3 earnings that exceeded expectations with EPS 13% above consensus, driven by a successful turnaround strategy focusing on shedding unprofitable patient groups and controlling costs. This led to a net margin increase from...
UnitedHealth Group reported third-quarter earnings that exceeded analyst expectations, with adjusted earnings per share of $4.69 versus the expected $4.14, and revenue of $112.69 billion. The company raised its fiscal 2026 adjusted earnings forecast ...
